期刊文献+

氯吡格雷关键中间体S-(+)-(2-噻吩乙胺基)(2-氯苯基)乙酸甲酯的合成研究 被引量:1

Study on synthesis of key intermediate of Clopidogrel of S-(+)-Methyl-α-(2-Thienylethylamino)(2-Chlorophenyl) Aectate
在线阅读 下载PDF
导出
摘要 目的研究氯吡格雷的中间体(S)-(+)-(2-噻吩乙胺基)(2-氯苯基)乙酸甲酯的合成。方法以(S)-邻氯苯甘氨酸甲酯的酒石酸盐、噻吩乙醇对甲苯磺酸酯等为原料,经中和、亲核取代反应合成目标化合物,考察溶剂、缚酸剂、原料比对产率的影响。结果目标化合物经1H-NMR、13C-NMR确证化学结构,确定了最佳实验条件为原料比(氨基酸酯∶磺酸酯)为2∶1、溶剂为乙腈、缚酸剂为磷酸氢二钾,产率达到80%,纯度高达99%。结论本研究为(S)-(+)-2-噻吩乙胺基-2-氯苯基乙酸甲酯的工业化生产提供了较为合理的工艺路线,也为氯吡格雷生产提供了合格的原料。 Objective To study the synthesis of S - (+) - Methyl -α- (2-Thienylethylamino) (2-Chlorophenyl) Aeetate. Methods S - (+) - Methyl - α- (2-Thienylethylamino) (2-Chlorophenyl) Aectate was synthesised by using (+) - Tartrate of Methyl (+) - α- Amino (2-ehlorophenyl) Acetate and 2 - (2-Thienyl) Ethyl toluene - p - sulphonate as starting materials by neutralization reaction, nueleophilie substitution reaction and etc.. The effect of molar ratio of (+) - Tartrate of Methyl (+) - α- Amino (2-Chlorophenyl) Acetate to 2 - (2-Thienyl) Ethyl toluene - p - sulphonate, solvent and acid aeceptor on the yield of S - (+) - Methyl - α -(2-Thienylethylamino) (2-Chlorophenyl) Acetate were investigated. Results The chemical structure of the target compound was confirmed by IH-NMR, ^13C NMR. The yield of title compound was 80% and its HPLC purity was not less than 99% under the optimum reaction conditions of n [(+) - Tartrate of Methyl (+) -α - Amino (2-Chlorophenyl) Acetate)] : n [(2 - (2-Thienyl) Ethyl toluene - p - sulphonate)]=2:1, aeetonitrile for solvent and dipotassium hydrogen phosphate for acid aceeptor. Conclusion This article can provide a more reasonable route for the production process of S - (+) - Methyl - α - (2-Thienylethylamino) (2-Chlorophenyl) Aectate.
出处 《中国医药导报》 CAS 2012年第22期24-25,共2页 China Medical Herald
基金 广东省自然科学基金(项目编号:S2011010001556) 2009年广东省学科建设专项资金第三批资助项目(项目编号:2009400) 2010年广东省第三批科学事业费计划项目(项目编号:2010A030200038) 2011年广州市第五批科学技术经费项目(项目编号:2011J4100016)
关键词 (S)-(+)-(2-噻吩乙胺基)(2-氯苯基)乙酸甲酯 氯吡格雷 中间体 合成 S - (+) - Methyl - α - (2-Thienylethylamino) (2-Chlorophenyl) Acetate Clopidogrel Intermediate Synthesis
  • 相关文献

参考文献6

二级参考文献46

  • 1姜丹.急性缺血性脑血管病早期诊断和对策[J].安徽医药,2005,9(8):624-626. 被引量:12
  • 2Lodewijk E, Khatri HN. 2-(2-Nitrovinyl) thiophene reduction and synthesis of thieno [3,2-c] pyridine derivatives[P]. EP:342118,1989-11-15. (CA 1990,112:235278s)
  • 3Bousquet A, Calet S, Heymes A. Isopropyl 2-thienyl glycidate, process for its preparation, and its use as synthetic intermediate for ticlodine and clopidogrel[P]. EP: 465358,1992-01-08.(CA 1992,116:194139j)
  • 4Aubert D, Ferrand C, Maffrand JP. Thieno[3,2-c] pyridine derivatives and their therapeutical use[P]. EP:99802,1984-02-01. (CA 1984,100:191856z)
  • 5Bouisset M, Radisson J. Process for the preparation of phenylacetic derivatives of thienopyridines[P]. EP:420706,1991-04-03.(CA 1991,115:114486m)
  • 6(SAN0FI. Preparation of d-α-5-(4,5,6,7-tetrahydro [3.2-c] thienopyridyl)-2-(chlorophenyl)acetic acid methyl ester as antithrombotic [P]. JP: 63203684,1988-08-23). CA 1989,110:192801w
  • 7Ueda Y, Nakayama H. A process for preparation of 4,5,6,7-tetrahydro[3,2-c]pyridine and its salts as an intermediate for an antiinflammatory, vasodilating agent and blood platelet aggregation inhibitor[P]. JP: 62103088,1987-05-13.(CA 1998,108:21871y)
  • 8Anne-Archard G, Heymes A, Valette G. 2-(Thienyl) ethyl amines and 2-(3-thienyl)ethyl amines[P]. EP:69002, 1983-01-05.(CA 1983,99:22305z)
  • 9Khatri HN, Dehoff BS. Process for preparation of 2-thiophene ethanamine and its conversion to ticlopidine [P]. EP:439404,1991-07-31.(CA 1991,115:183123c)
  • 10(Sogo K, Yamane H. Manufacture of primary amines by lithium borohydride reduction of nitrile compounds[P]. JP:63255252,1988-10-12). CA 1989,110:156582d

共引文献55

同被引文献19

  • 1Sanofi. Dextro - rotatory enantiomer of methyl alpha -5(4,5,6,7 -tetrahydro(3,2 - c) thieno pyridyl) (2 - chlorophenyl) - acetate andthe pharmaceutical compositions containing it:US,4847265 [P]. 1989 -07-11.
  • 2Kim S D,KangW,LeeHW,et al. Bioequivalence and tolerability of twoclopidogrel salt preparations,besylate and bisulfate:a randomized,open -label,crossover study in healthy Korean male subjects [ J ].ClinicalTherapeutics,2009,31(4) :793 - 803.
  • 3Sanofi. Process for the preparation of a - bromo - phenylacetic acids:US,5036156 [P]. 1991 -07-30.
  • 4Ema T, Okita N, Ide S, et al. Highly enantioselective and efficientsynthesis of methyl ( R ) - o - chloromandelate with recombinant E.coli : toward practical and green access to clopidogrel [ J ]. Organic &biomolecular chemistry,2007,5(8) :1175 -1176.
  • 5Min Jeong, Yoon Mi Lee, Soon Ho Hong, et al. Optimization ofenantioselective synthesis of methyl ( R) - 2 - chloromandelate bywhole cells of Saccharomyces cerevisiae[ J]. Biotechnol Lett,2010,32(10):1529 -1531.
  • 6Lokeswara Rao Madivada, Raghupathi Reddy Anumala, GoverdhanGilla, et al. An efficient and large scale synthesis of Clopidogrel jAntiplatelet drug[ J]. Der Pharma Chemica,2012,4( 1 ) :479 -488.
  • 7Patrizia Ferraboschi, Maria De Mieri, Fiorella Galimberli. Chemo -enzymatic approach to the synthesis of the antithrombotic clopidogrel[J] . Tetrahedron : Asymmetry ,2010,21 ( 17 ) :2136 - 2141.
  • 8Isabelle Aillaud, Caroline Haurena, Erwan Le Gall, et al. 2 -Chlorophenyl Zinc Bromide : A Convenient Nucleophile forthe Mannich -Related Multicomponent Synthesis of Clopidogrel and Ticlopidine [ J].molecules,2010,(15) :8144 -8155.
  • 9Kiwon Junga, Jae - Sun Kim,Tae - Hyun Kimc,et al. A Facile Solid -? Phase Synthesis of(+)-(S) - Clopidogrel [ J]. Helvetica ChimicaActa,2013,96(2) :326 -329.
  • 10唐田,王彦青,王海全,蔡敏英.氯吡格雷硫酸氢盐的合成[J].中国医药工业杂志,2009,40(5):324-326. 被引量:6

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部